This report was first published by Endpoints News. To see the original version, click here
China is “eating our lunch” on new drug approvals and clinical trial starts, HHS Secretary Robert F. Kennedy Jr. told Congress Tuesday, while praising the FDA’s actions so far.
“We are losing scientists, we’re losing our IP, we’re losing physicians, we’re losing the best researchers, and we’re going to lose our biosecurity,” Kennedy said in response to questions from Rep. Brett Guthrie (R-KY) on Chinese innovation.
您已阅读16%（507字），剩余84%（2722字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。